Given investment horizon of 30 days, Delcath Systems Inc. is expected to under-perform the Nektar. In addition to that, Delcath is 1.55 times more volatile than Nektar Therapeutics. It trades about -0.17 of its total potential returns per unit of risk. Nektar Therapeutics is currently generating about -0.14 per unit of volatility. If you would invest 782 in Nektar Therapeutics on April 25, 2012 and sell it today you would lose (82.00) from holding Nektar Therapeutics or give up 10.49% of portfolio value over 30 days.
Diversification
Very weak diversification
Overlapping area represents amount of risk that can be diversified away by holding Delcath Systems Inc. and Nektar Therapeutics in the same portfolio (assuming nothing else is changed)
USA 
Select Assests
Optimize Portfolio
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatilities
Import Equities
Search Equities
